Vaccines

Small Pox Vaccine

This research study will evaluate the safety and effectiveness of a vaccine to protect against Smallpox. This study will last approximately up to 39 weeks with 6 number of visits to our office and 1 telephone call. While the World Health Organization officially declared successful global eradication in 1980, the threat of a small pox outbreak still exists though bioterrorism and rish of natural re-emergence of the virus.

*Compensation for time and travel may be available to those who qualify.

E. Coli Vaccine

RCR is currently enrolling healthy 60-85 year olds to evaluate a vaccine that could potentially prevent E. Coli that can cause sepsis.

C. Diff. Vaccine

Investigational vaccine to prevent Clostridium Difficile

*Compensation for time and travel may be available to those who qualify.

RSV Vaccine

The purpose of the research study is to evaluate the safety and effectiveness of the study vaccine to prevent respiratory syncytial virus (RSV). The research study will last approximately 14 months with 9 visits to our office.
There is no cost for participating in the research study and you will be compensated up to $450 for your time and travel, if you qualify.

*Compensation for time and travel may be available to those who qualify.

Pneumococcal Vaccine

This study is to evaluate the safety and effectiveness of the study vaccine that may protect against pneumococcal pneumonia. The study will last approximately 6 months, with 2 visits to our office and 1 telephone call. Compensation for time and travel may be available up to $100 for those who qualify.

*Compensation for time and travel may be available to those who qualify.

Pediatrics Meningitis Vaccine

Two month old patients of Legacy Pediatrics may have an opportunity to participate in this study.